GlassScriptPhysician profile
Michael M Tucker
NPI 1841232691
$5,683.65
in general payments reported to CMS, 2019-2025
16 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $181 · 2021: $165 · 2022: $273 · 2023: $4,442 · 2024: $205 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,024 · Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,024.30 |
| Food and Beverage | $841.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $4,053.63 | 2021-2023 | |
| Stryker Corporation | $473.76 | 2020-2025 | Aequalis Perform Reversed, Mako |
| Arthrex, INC. | $361.13 | 2023-2025 | |
| Horizon Therapeutics Plc | $268.12 | 2019-2023 | Krystexxa |
| Depuy Synthes Sales INC. | $180.59 | 2022 | |
| Medtronic, INC. | $109.43 | 2021 | |
| Pacira Therapeutics, INC. | $39.61 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $36.28 | 2025 | Exparel |
| Ferring Pharmaceuticals INC. | $34.97 | 2022-2023 | Euflexxa |
| Orthofix Medical, INC. | $25.57 | 2019 | |
| Viiv Healthcare Company | $23.25 | 2024 | Rukobia |
| Impel Pharmaceuticals INC. | $20.72 | 2022 | |
| Paragon 28, INC. | $18.60 | 2021 | |
| Amgen INC. | $14.28 | 2024 | Krystexxa |
| Next Science LLC | $11.95 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.